News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 02, 2019, 07:45 ET CytoSorbents to Present at the Piper Jaffray 31st Annual Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Nov 25, 2019, 07:00 ET CytoSorbents Changes Contract Research Organizations and Temporarily Pauses Enrollment in REFRESH 2-AKI Study

CytoSorbents Corporation (NASDAQ: CTSO) is temporarily pausing enrollment of its REFRESH 2-AKI study at the recommendation of its Data Monitoring...


Nov 19, 2019, 07:00 ET CytoSorbents to Present at the Three Part Advisors 2019 Southwest IDEAS Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Nov 06, 2019, 17:20 ET Dr. Eric Mortensen to Leave CytoSorbents At Year End

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Nov 05, 2019, 16:15 ET CytoSorbents Reports Third Quarter 2019 Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Nov 04, 2019, 07:05 ET CytoSorbents Announces Additions to its International Clinical Team

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Nov 01, 2019, 07:15 ET CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom

CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies to treat life-threatening conditions, announced the first patient...


Oct 30, 2019, 07:30 ET CytoSorbents to Report Q3 2019 Operating and Financial Results

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly...


Oct 22, 2019, 08:12 ET CytoSorbents Awarded Approximately $3.0 Million by the U.S. Air Force to Advance Development of the K+ontrol System to Treat Severe Hyperkalemia

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that the U.S. Air...


Oct 10, 2019, 07:00 ET CytoSorbents to Present at The MicroCap Rodeo Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Oct 04, 2019, 07:08 ET CytoSorb® Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac Surgery

CytoSorbents Corporation (NASDAQ: CTSO), a leader in hemoadsorption therapies to treat life-threatening conditions, announced that Dr. Eric...


Oct 02, 2019, 08:24 ET CytoSorbents Announces Positive Surgical Outcomes From CytoSorb Removal Of Antithrombotics In Emergency Cardiothoracic Surgery

CytoSorbents Corporation (NASDAQ: CTSO), a leader using its CytoSorb® blood purification technology to treat life-threatening medical and surgical...


Sep 25, 2019, 06:58 ET CytoSorbents Highlights Survival Benefit of CytoSorb Therapy in Septic Shock

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Sep 16, 2019, 07:00 ET First Study to Evaluate CytoSorb in Cytokine Release Syndrome (CRS) Following CAR T-cell Immunotherapy to Commence

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Sep 13, 2019, 07:08 ET World Sepsis Day 2019: CytoSorbents Highlights Its Support of Multiple Organizations In the Fight Against Sepsis

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to help...


Sep 09, 2019, 07:00 ET CytoSorbents to Present at the H.C. Wainwright 21st Annual Global Investment Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Aug 28, 2019, 09:51 ET CytoSorbents Highlights Recent Published Studies on CytoSorb

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Aug 15, 2019, 13:54 ET CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Aug 13, 2019, 07:08 ET CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Aug 06, 2019, 16:15 ET CytoSorbents Reports Record Second Quarter 2019 Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Aug 05, 2019, 17:00 ET CytoSorbents Announces Amendment to Loan Agreement with Bridge Bank, Receives an Additional $5 Million Cash from New Term Loan

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly...


Jul 30, 2019, 07:00 ET CytoSorbents to Report Q2 2019 Operating and Financial Results

CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Jun 18, 2019, 06:30 ET CytoSorbents to Present at the Raymond James Life Sciences and MedTech Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Jun 11, 2019, 07:00 ET CytoSorbents to Present at the Three Part Advisors 2019 East Coast IDEAS Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Jun 03, 2019, 07:00 ET CytoSorbents to Present at the Jefferies 2019 Global Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...